Trials / Terminated
TerminatedNCT06295354
Early Variations in Immune Aging
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Background: Despite an increase in lifespan over the last decades, our healthspan lags behind. In our aging population, it is pressing that we prevent age-related morbidities and associated burden on the health care system. Instead of investigating aging in already aged populations, the currently proposed study aims to elucidate the process of immune aging in relation to biological aging, demographic and lifestyle factors in young and midlife adults, and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes. Study design: A single-center, observational prospective cohort study in the Netherlands. Participants from priorly established cohorts will be invited to join the EVIA-study. We will obtain demographic and basic clinical data and biological samples (blood and stool) at baseline and after three years, with a short, yearly online questionnaire in between.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention, we just study 'aging' | No intervention, we just study 'aging' |
Timeline
- Start date
- 2024-10-07
- Primary completion
- 2025-01-27
- Completion
- 2025-03-18
- First posted
- 2024-03-06
- Last updated
- 2025-05-01
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06295354. Inclusion in this directory is not an endorsement.